Sanofi SA (ADR) (NYSE:SNY) Walks Out From KaloBios Pharmaceuticals Inc (NASDAQ:KBIO)’s KB001-A Deal

Boston, MA 07/29/2014 (wallstreetpr) – During the 2013’s era of biotech boom, KaloBios Pharmaceuticals Inc (NASDAQ:KBIO) had debuted on the exchange with high promises to deliver, which had instantly caught attention of giants like Sanofi SA (ADR) (NYSE:SNY). The latter had agreed to partner KaloBios in a deal by paying $35 million and had announced […]

KaloBios Pharmaceuticals Inc (NASDAQ:KBIO) focus on developing protein therapeutics

Boston, MA 06/07/2013 (wallstreetpr) – KaloBios Pharmaceuticals Inc (NASDAQ:KBIO) in the previous trading session closed at $5.15 after going down by $0.29 (-5.33%) which closed at $5.44 in the previous trading session of Wednesday. The stock opened its day at $5.36 and hit the day’s low at $4.90 and the day’s high at $5.42. The volume […]